medline.ch Dermatologie Psoriasis

	Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study. J Dermatolog Treat Muheyati D, Jiang Y, Xuan Z, Li S, Cui L, Ma R, Wang Y, Wang Y, Liu T, Zhang Y, Yu Q, Bi X, Shi Y. PMID: 42592795 [PubMed - indexed for MEDLINE]
	Correspondence on: "Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY Study". Arthritis Rheumatol Choudhuri B. PMID: 42592786 [PubMed - as supplied by publisher]
	Pilot validation of the genital psoriasis reported outcomes questionnaire in an Italian cohort. Front Med (Lausanne) Artosi F, Campione E, Lambiase S, Cattani C, Botti E, Zangrilli A, Bianchi L. PMID: 42591260 [PubMed]
	Association of IL-17 inhibitor therapy with glycemic, lipid profiles, and systemic inflammation in psoriasis patients with metabolic comorbidities: a retrospective cohort study. Front Med (Lausanne) Zhang X, Zhang M, Nie Z, Xu Y, Xu H, Li Y, Li J, Zhu M, Li J. PMID: 42591095 [PubMed]
	Potential Blood Biomarkers Predicting Treatment Response in Psoriasis: A Systematic Review and Meta-Analysis. J Clin Med Villa-Gonzalez JM, Arevalo-Ortega I, Gonzalez-Hermosa MR, Gonzalez S, Rashid S, Tsao H, Izu-Belloso R. PMID: 42590198 [PubMed]
	Inflammatory Manifestations, Therapeutic Interventions, and Cancer Risk in Psoriasis: Current Epidemiological and Mechanistic Evidence. Int J Mol Sci Lymperi A, Lamprianidou E, Adamantidi T, Chatzikamari M, Loizidis N, Dania V, Tsoupras A. PMID: 42589436 [PubMed - indexed for MEDLINE]
	Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety. J Dermatol Hagino T, Kanda N. PMID: 42587407 [PubMed - as supplied by publisher]
	Response to the letter by Ghanim et al, "Comment on Gao et al.'s 'A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis'". J Am Acad Dermatol Shi Y. PMID: 42586274 [PubMed - as supplied by publisher]
	Comment on Gao et al.'s "A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis". J Am Acad Dermatol Ghanim D, Ghebrial M, Tognaccini C, Thomas LE, Ansari Z, Gupta K, Wu JJ. PMID: 42586268 [PubMed - as supplied by publisher]
	Efficacy and Safety of Ustekinumab Biosimilars in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-analysis. Clin Drug Investig Rashid M, Muhammad A, Saeed E, Qureshi AA, Mubashir MM, Waqas Bin Waheed M, Yasin MA, Abdullah M, Rashid A, Zubair Z. PMID: 42584528 [PubMed - as supplied by publisher]
	Biologic DMARD class influences progression from psoriasis to PsA: A real-world cohort study. Rheumatology (Oxford) Kougkas N, Sotiriou E, Deligeorgakis D, Skepastianos V, Skouvaklidou E, Tsafis K, Vergou T, Michalakeas N, Papadimitriou I, Dimitroulas T, Fragoulis GE. PMID: 42584086 [PubMed - as supplied by publisher]
	Efficacy and safety of different doses of apremilast in mild to-moderate psoriasis: A randomized controlled study. Indian J Pharmacol Anil A, Saravanan A, Budania A, Yadav I, Dwivedi P, Varthya SB, Ambwani S, Singh S. PMID: 42583969 [PubMed - indexed for MEDLINE]
	Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review. J Dermatolog Treat Armstrong AW, Strober BE, Liu CM, Cather JC, Merola JF, Lebwohl MG. PMID: 42581417 [PubMed - indexed for MEDLINE]
	Prevalence of psoriasis in indigenous communities around the world: a scoping review(â‹†). An Bras Dermatol Yang Y, Lee S, Lai FYX, Romiti R. PMID: 42579910 [PubMed - as supplied by publisher]
	Impact of Biologic Therapies on the Risk of Progression from Psoriasis to Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Cohort Studies. Am J Clin Dermatol Xie W, Chen T, Chen Y, Xiao S. PMID: 42579249 [PubMed - as supplied by publisher]
	MRI-defined sacroiliitis and spinal inflammation in chronic back pain: real-world patterns in axial spondyloarthritis and axial psoriatic arthritis. Rheumatol Adv Pract Parada M, Molina ML, Ríos D, Suárez D, Ochoa M, Hitchin N, Bravo C, Guzmán N, Barahona P, Goecke A. PMID: 42578246 [PubMed]
	Comorbid mechanisms of psoriasis and mental disorders: an analysis of inflammatory and psychosocial interactions. Front Psychiatry Qin B, Pang H, Huang Y, Chen C, Yang Y, Tian Y, Zhang Y. PMID: 42577607 [PubMed]
	Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial. Lancet Reg Health Eur van den Reek JMPA, van Riel CAM, Soenen R, Eylenbosch A, Schots L, van der Schoot LS, Grine L, Hannink G, Willaert F, Hillary T, van Lümig PPM, Ghislain PD, Ossenkoppele PM, Lanssens S, Prens BSP, Temmerman L, van Doorn MBA, van der Voort EAM, Haeck I, Huizinga J, Nikkels AF, Dierckxsens L, Berends MAM, Dodemont SRP, Bovenschen J, Lambert JLW, de Jong EMGJ. PMID: 42577288 [PubMed]
	Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study. Dermatol Ther (Heidelb) Bewley A, Pinter A, López Estebaranz JL, Galván J, Sapena V, Koscielny V. PMID: 42573965 [PubMed - as supplied by publisher]
	Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review. Immunol Res Rasouli A, Heidari N, Heidari A, Khalifezadeh M, Goodarzi A. PMID: 42573865 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 28393

Seite 1 von 1420

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung